Thölking, G.; Gillhaus, N.H.; Schütte-Nütgen, K.; Pavenstädt, H.; Koch, R.; Suwelack, B.; Reuter, S.
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation. J. Clin. Med. 2020, 9, 328.
https://doi.org/10.3390/jcm9020328
AMA Style
Thölking G, Gillhaus NH, Schütte-Nütgen K, Pavenstädt H, Koch R, Suwelack B, Reuter S.
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation. Journal of Clinical Medicine. 2020; 9(2):328.
https://doi.org/10.3390/jcm9020328
Chicago/Turabian Style
Thölking, Gerold, Nils Hendrik Gillhaus, Katharina Schütte-Nütgen, Hermann Pavenstädt, Raphael Koch, Barbara Suwelack, and Stefan Reuter.
2020. "Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation" Journal of Clinical Medicine 9, no. 2: 328.
https://doi.org/10.3390/jcm9020328
APA Style
Thölking, G., Gillhaus, N. H., Schütte-Nütgen, K., Pavenstädt, H., Koch, R., Suwelack, B., & Reuter, S.
(2020). Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation. Journal of Clinical Medicine, 9(2), 328.
https://doi.org/10.3390/jcm9020328